Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial.
Cox RJ, Pedersen G, Madhun AS, Svindland S, Sævik M, Breakwell L, Hoschler K, Willemsen M, Campitelli L, Nøstbakken JK, Weverling GJ, Klap J, McCullough KC, Zambon M, Kompier R, Sjursen H. Cox RJ, et al. Among authors: weverling gj. Vaccine. 2011 Oct 19;29(45):8049-59. doi: 10.1016/j.vaccine.2011.08.042. Epub 2011 Aug 22. Vaccine. 2011. PMID: 21864624 Clinical Trial.
The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: data from a randomized, Phase III study.
Esposito S, Marchisio P, Montinaro V, Bianchini S, Weverling GJ, Pariani E, Amendola A, Fabiano V, Pivetti V, Zanetti A, Zuccotti GV. Esposito S, et al. Among authors: weverling gj. Vaccine. 2012 Nov 19;30(49):7005-12. doi: 10.1016/j.vaccine.2012.09.069. Epub 2012 Oct 8. Vaccine. 2012. PMID: 23059357 Clinical Trial.
First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.
Bakker AB, Python C, Kissling CJ, Pandya P, Marissen WE, Brink MF, Lagerwerf F, Worst S, van Corven E, Kostense S, Hartmann K, Weverling GJ, Uytdehaag F, Herzog C, Briggs DJ, Rupprecht CE, Grimaldi R, Goudsmit J. Bakker AB, et al. Among authors: weverling gj. Vaccine. 2008 Nov 5;26(47):5922-7. doi: 10.1016/j.vaccine.2008.08.050. Epub 2008 Sep 17. Vaccine. 2008. PMID: 18804136 Clinical Trial.
Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
Samina I, Havenga M, Koudstaal W, Khinich Y, Koldijk M, Malkinson M, Simanov M, Perl S, Gijsbers L, Weverling GJ, Uytdehaag F, Goudsmit J. Samina I, et al. Among authors: weverling gj. Vaccine. 2007 Nov 28;25(49):8338-45. doi: 10.1016/j.vaccine.2007.09.055. Epub 2007 Oct 15. Vaccine. 2007. PMID: 17977629
Multi-Omics Analysis Reveals MicroRNAs Associated With Cardiometabolic Traits.
Mens MMJ, Maas SCE, Klap J, Weverling GJ, Klatser P, Brakenhoff JPJ, van Meurs JBJ, Uitterlinden AG, Ikram MA, Kavousi M, Ghanbari M. Mens MMJ, et al. Among authors: weverling gj. Front Genet. 2020 Feb 27;11:110. doi: 10.3389/fgene.2020.00110. eCollection 2020. Front Genet. 2020. PMID: 32174972 Free PMC article.
123 results